CN Patent

CN104583196A — 1,4-二取代的哒嗪类似物以及治疗与smn缺乏相关的病症的方法

Assigned to Novartis AG · Expires 2015-04-29 · 11y expired

What this patent protects

本发明提供了式(I)化合物或其可药用盐；生产本发明化合物的方法及其治疗用途。本发明还提供了药学活性剂的组合产品以及药物组合物。

USPTO Abstract

本发明提供了式(I)化合物或其可药用盐；生产本发明化合物的方法及其治疗用途。本发明还提供了药学活性剂的组合产品以及药物组合物。

Drugs covered by this patent

Patent Metadata

Patent number
CN104583196A
Jurisdiction
CN
Classification
—
Expires
2015-04-29
Drug substance claim
No
Drug product claim
No
Assignee
Novartis AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.